Literature DB >> 52214

Leishmaniasis in Brazil: X. Some observations of intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis.

J J Shaw, R Lainson.   

Abstract

In spite of the difficulty of antigen standardization, paired intradermal skin tests demonstrated qualitative differences between leishmanin and in vitro exo-antigen. Some of these differences may be due to the destruction of certain antigens by phenol, while others seem to reflect basic antigenic differences. Leishmania mexicana amazonensis in vitro exo-antigen produced immediate anaphylactic reponses in 74.4% of the patients with parasitologically proven cutaneous leishmaniasis. Although more individuals responded to leishmanin, 82.4% as compared to 73.9%, the leishmanial in vitro exo-antigen gave significantly larger delayed responses, Trypanosoma cruzi trypamosomin elicited delayed reactions, while trypanosomal in vitro exo-antigen only produced immediate anaphylactic reactions in persons with active cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52214     DOI: 10.1016/0035-9203(75)90127-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Molecular cloning and characterization of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis.

Authors:  K L Lohman; P J Langer; D McMahon-Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Cell surface origin of antigens shed by Leishmania donovani during growth in axenic culture.

Authors:  E S Kaneshiro; M Gottlieb; D M Dwyer
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

3.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

4.  Exometabolites of Leishmania donovani promastigotes. II. Spontaneous changes of exometabolite after isolation.

Authors:  L H Semprevivo; B M Honigberg
Journal:  Z Parasitenkd       Date:  1980

5.  Regulation of immunoglobulin E production in mice immunized with an extract of Toxoplasma gondii.

Authors:  N Watanabe; A Kobayashi
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

6.  Development, characterization, and in vitro biological performance of fluconazole-loaded microemulsions for the topical treatment of cutaneous leishmaniasis.

Authors:  Marcela Brito Oliveira; Giovana Calixto; Márcia Graminha; Hugo Cerecetto; Mercedes González; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2015-01-12       Impact factor: 3.411

7.  Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina.

Authors:  Alejandro Javier Krolewiecki; Maria Cristina Almazan; Marcelo Quipildor; Marisa Juarez; Jose Fernando Gil; Marco Espinosa; Maria Canabire; Silvana Pamela Cajal
Journal:  PLoS Negl Trop Dis       Date:  2017-10-05

8.  Occupationally acquired american cutaneous leishmaniasis.

Authors:  Maria Edileuza Felinto de Brito; Maria Sandra Andrade; Ericka Lima de Almeida; Angela Cristina Rapela Medeiros; Roberto Pereira Werkhäuser; Ana Isabele Freitas de Araújo; Sinval Pinto Brandão-Filho; Alzira Maria Paiva de Almeida; Eduardo Henrique Gomes Rodrigues
Journal:  Case Rep Dermatol Med       Date:  2012-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.